BS
AZN icon

Banco Santander’s AstraZeneca AZN Stock Holding History

Banco Santander’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$677K Sell
3,569
-2,119
-37% -$399K ﹤0.01% 377
2026
Q1 		$1.14M Buy
+5,688
New +$1.1M 0.01% 324
2025
Q3 		– Sell
-10,800
Closed -$1.51M – 478
2025
Q2 		$1.51M Buy
10,800
+2,425
+29% +$340K 0.01% 299
2025
Q1 		$1.23M Buy
8,375
+230
+3% +$33.3K 0.01% 299
2024
Q4 		$1.07M Buy
8,145
+460
+6% +$64.4K 0.01% 276
2024
Q3 		$1.2M Sell
7,685
-1,100
-13% -$178K 0.01% 271
2024
Q2 		$1.37M Buy
8,785
+2,385
+37% +$359K 0.02% 248
2024
Q1 		$867K Sell
6,400
-5,585
-47% -$740K 0.01% 287
2023
Q4 		$1.61M Sell
11,985
-5,375
-31% -$699K 0.02% 245
2023
Q3 		$2.35M Sell
17,360
-9,428
-35% -$1.29M 0.03% 225
2023
Q2 		$3.83M Buy
26,788
+6,498
+32% +$956K 0.05% 181
2023
Q1 		$2.82M Sell
20,290
-195
-1% -$26.2K 0.04% 161
2022
Q4 		$2.78M Buy
20,485
+220
+1% +$27.6K 0.04% 157
2022
Q3 		$2.22M Sell
20,265
-7,450
-27% -$945K 0.03% 180
2022
Q2 		$3.66M Buy
27,715
+3,740
+16% +$491K 0.05% 170
2022
Q1 		$3.18M Buy
23,975
+9,995
+71% +$1.2M 0.03% 199
2021
Q4 		$1.63M Buy
13,980
+3,115
+29% +$367K 0.01% 258
2021
Q3 		$1.3M Buy
10,865
+6,875
+172% +$800K 0.01% 264
2021
Q2 		$478K Sell
3,990
-715
-15% -$78.4K ﹤0.01% 326
2021
Q1 		$468K Sell
4,705
-120
-2% -$12.1K ﹤0.01% 323
2020
Q4 		$482K Buy
+4,825
New +$511K ﹤0.01% 310
2019
Q1 		– Sell
-14,745
Closed -$1.12M – 359
2018
Q4 		$1.12M Sell
14,745
-6,020
-29% -$470K 0.01% 231
2018
Q3 		$1.64M Sell
20,765
-2,210
-10% -$167K 0.02% 212
2018
Q2 		$1.61M Buy
+22,975
New +$1.65M 0.02% 206

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Banco Santander's AZN Position: Q2 2026 in Review

Banco Santander reduced its AstraZeneca (AZN) stake by 37% in Q2 2026, selling an estimated $399K and leaving 3,569 shares worth $677K. The position accounts for ﹤0.01% of the portfolio, ranked #377.

Banco Santander first reported a position in AZN in Q2 2018 and has held it in 24 quarters since. The position peaked at $3.83M in Q2 2023. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Banco Santander held 3,569 shares of AstraZeneca worth $677K as of Q2 2026.
  • Banco Santander sold 2,119 AstraZeneca shares in Q2 2026, an estimated $399K.
  • AstraZeneca made up ﹤0.01% of Banco Santander's portfolio in Q2 2026, its #377 holding.
  • Banco Santander first reported a position in AstraZeneca in Q2 2018 and has held it in 24 quarters since.
  • Banco Santander's AstraZeneca position peaked at $3.83M in Q2 2023.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Banco Santander's 13F filing for Q2 2026, filed 29 Jul 2026.